Heron Therapeutics Inc HRTX:NASDAQ

Last Price$19.29NASDAQ Previous Close - Last Trade as of 4:15PM ET 6/05/20

Today's Change+0.86(4.67%)
Bid (Size)$19.16 (23)
Ask (Size)$19.75 (1)
Day Low / High$18.56 - 19.51
Volume882.3 K

Heron Therapeutics Says Drug for Postoperative Pain Receives Priority Review Status From Health Canada

9:11AM ET 12/03/2019 MT Newswires
Heron Therapeutics (HRTX) said Tuesday that Health Canada has accepted and granted a Priority Review Status for HTX-011, which is intended for the management of postoperative pain.

The Priority Review status is granted for drug submissions that aim to treat, prevent or diagnose serious, life-threatening or severely debilitating illnesses and conditions.

Price: 26.17, Change: +0.61, Percent Change: +2.33